The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis

Area of Science:

• Oncology
• Vascular Biology
• Pharmacology

Background:

• Tumor vasculature is crucial for cancer cell dissemination and metastasis.
• Vessel targeting therapy is a key strategy in managing metastatic cancers.
• Understanding angiogenesis is vital for developing effective cancer treatments.

Purpose of the Study:

• To review the role of angiogenesis in tumor metastasis.
• To summarize FDA-approved vessel targeting drugs for metastatic cancers.
• To discuss the application, mechanisms, risks, and countermeasures of vascular targeting drugs.

Main Methods:

• Literature review of angiogenesis and metastasis.
• Analysis of FDA-approved vessel targeting agents.
• Discussion of clinical applications and therapeutic strategies.

Main Results:

• Angiogenesis significantly contributes to tumor cell escape and distant metastasis.
• Several FDA-approved drugs target tumor vasculature to inhibit metastasis.
• Vascular targeting drugs offer promising therapeutic avenues with manageable risks.

Conclusions:

• Vessel targeting therapy is an effective strategy against metastatic cancer.
• Understanding drug mechanisms and potential risks is crucial for optimal patient outcomes.
• Further research into vascular targeting drugs can improve cancer treatment efficacy.